The economic burden of antimicrobial resistance (AMR) significantly exceeds the confines of the clinical world, with lasting repercussions for a society's health and financial systems, as explained by Kevin Outterson, a professor at Boston University and founding executive director of CARB-X, in a recent interview with Infection Control Today®(ICT®). The conversation unveiled a critical discrepancy…
While one might initially think of atypical factors such as scientific research and behavior modification when it comes to managing infectious disease, an incredibly vital yet vulnerable aspect lies in the economic systems facilitating infection control practices. The impact of global economic instability on these systems was exhibited during a recent World Health Organization (WHO)…
Nosocomial Infections (NIs), often colloquially known as hospital-acquired infections, have a significant impact on patient outcomes, increasing both mortality rates and the deterioration of health-related quality of life. Above and beyond these daunting repercussions, NIs exert considerable economic pressure on the healthcare segments, particularly hospitals. For instance, these infections cause extended hospital stays, resulting in…